Limited Competition for the Continuation of the Assessment, Serial Evaluation and Subsequent Sequelae of Acute Kidney Injury (ASSESS AKI) Study (U01)

 

The purpose of this limited competition is to extend the activities of the ASSESS AKI consortium to continue an observational cohort of patients with normal renal function and with chronic kidney disease (CKD) who have had an episode of AKI and appropriate control participants to ascertain a) long-term renal functional outcomes, b) long-term cardiovascular disease outcomes, c) quality of life and cognitive functional outcomes, and d) survival. In addition, the utility of putative biomarkers to predict short and long-term outcomes will be assessed. The extension will insure the statistical power and the significance of the study outcomes. The extension will insure the statistical power and significance of the study outcomes. The ASSESS AKI is comprised of three Participating Clinical Centers (PCCs) and a data Coordinating Center. An additional site was added as an ancillary study in 2010.

Deleted 12/22/2012 (Archived.) RFA-DK-12-509 Agency: Department of Health and Human Services
Office: National Institutes of Health Cooperative Agreement Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. 11/21/2012 This program does not have cost sharing or matching requirements. NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-12-509.html FBOWebmaster@OD.NIH.GOV $2,200,000.00